Syngulon

Syngulon develops original genetic technologies using bacteriocins to improve microbial fermentation. The company operates as a 'Startup in the Labs,' working directly in academic partner laboratories across Belgium, Brazil, France, Germany, The Netherlands, and the UK. Bacteriocins are ribosomally-produced, genetically encoded antimicrobial peptides that can be modified using synthetic biology.